Abstract
α-Chain disease (α-CD) is defined as a B-lymphoid cell proliferation involving first and foremost the IgA secretory system and producing a presumably homogeneous population of immunoglobulin molecules consisting of incomplete α-chains and devoid of light chains. It is the most frequent of the heavy chain diseases and, since its initial description in 1968 [15, 26], more than 120 cases have been recognized to our knowledge. All these patients, except three who showed an involvement of the respiratory tract, were affected with the digestive form of α-CD which is mainly located in the small intestine and the mesenteric lymph nodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bognel, J. C., Rambaud, J. C., Modigliani, R., Matuchansky, C., Bognel, C., Bernier, J. J., Scotto, J., Hautefeuille, P., Mihaesco, E., Hurez, D., Preud’Homme, J. J., Seligmann, M.: Etude clinique, anatomo-pathologique et immunochimique d’un nouveau cas de maladie des chaînes alpha suivi pendant cinq ans. Rev. Eur. Et. Clin. Biol. 17 ,362–374 (1972).
Brouet, J. C, Mason, D. Y., Danon, F., Preud’Homme, J. L., Seligmann, M., Reyes, F., Navab, F., Galian, A., Rene, E., Rambaud, J. C.: Alpha-chain disease: Evidence for common clonal origin of intestinal immunoblastic lymphoma and plasmacytic proliferation. Lancet. 7, 861 (1977).
Chadli, A., Hafsia, M, Maamouri, M. T., Haddad, N., Ayed, K.: Lymphome méditerranéen avec maladie des chaînes alpha. Etude anatomo-pathologique à propos du premier cas tunisien. Arch. Anat. Pathol. (Paris) 21 ,199–210 (1973).
Cowan, N. J., Secher, D. S., Milstein, C: Intracellular immunoglobulin chain synthesis in nonsecreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. J. Mol. Biol. 90 ,691–701 (1974).
Doe, W. F.: Alpha chain disease. Clinicopathological features and relationship to so-called Mediterranean lymphoma. Br. J. Cancer, 31 ,suppl. II, 350–355 (1975).
Dutz, W., Asvadi, S., Sadri, S., Kohout, E.: Intestinal lymphoma and sprue: a systematic approach. Gut 12 ,804–810 (1971).
Galian, A., Lecestre, M. J., Scotto, J., Bognel, C., Matuchansky, C., Rambaud, J. C: Pathological study of alpha chain disease, with special emphasis on evolution. Cancer 39 ,2081–2101 (1977).
Guardia, J., Moragas, A., Pedreira, J. D., Ferragut, A., Gomez-Perez, J., Martinez-Vasquez, J. M., Llorens, V.: Enfermedad de lad cadenas pesadas alfa (Enfermedad de Seligmann). Rev. Clin. Esp. 127, 923–926(1972).
Jones, P. P., Craig, S. W., Cebra, J. J., Herzenberg, L. A.: Restriction of gene expression in B lymphocytes and their progeny. II. Commitment to immunoglobulin heavy chain isotype. J. Ex. Med. 140 ,452–469 (1974).
Laroche, C., Seligmann, M., Merillon, H., Turpin, G., Marche, C., Cerf, M., Lemaigre, G., Forest, M., Hurez, D.: Nouvelle observation d’une maladie des chaînes lourdes alpha au cours d’un lymphome abdominal de type méditerranéen avec tuberculose isolée des ganglions mésentériques et pelvi-spondylite. Presse Med. 78 ,55–59 (1970).
Lewin, K. J., Kahn, L. B., Novis, B. H.: Primary intestinal lymphoma of “western” and “mediterranean” type, alpha chain disease and massive plasma cell infiltration. A comparative study of 37 cases. Cancer 38 ,2511–2528 (1976).
Manousos, O. N., Economidou, J. C., Georgiadou, D. E., Pratsika-Ougourloglou, K. G., Hadziyannis, S. J., Merikas, G. E., Henry, K., Doe, W. F.: Alpha-chain disease with clinical, immunological and histological recovery. Br. Med. J. 2 ,409–412 (1974).
Monges, H., Aubert, L., Chamlian, A., Remacle, J. P., Mathieu, B., Cougard, A., Arroyo, H.: Maladie des chaînes alpha à forme intestinale. Présentation d’un cas traité par antibiothérapie avec rémission clinique, histologique et immunologique. Arch. Fr. Mal. App. Dig. 64 ,223–231 (1975).
Parrott, D. M. V.: The gut as a lymphoid organ. Clin. Gastroenterol. 5, 211–228 (1976).
Rambaud, J. C., Bognel, C., Prost, A., Bernier, J. J., Le Quintrec, Y., Lambling, A., Danon, F., Hurez, D., Seligmann, M.: Clinico-pathological study of a patient with “Mediterranean” type of-abdominal lymphoma and a new type of IgA abnormality (“alpha chain disease”). Digestion 1 ,321336 (1968).
Rambaud, J. C., Matuchansky, C.: Alpha-chain disease. Pathogenesis and relation to Mediterranean lymphoma. Lancet 1 ,1430–1432 (1973).
Rambaud, J. C., Matuchansky, C., Bognel, J. C., Bognel, C., Bernier, J. J., Scotto, J., Perol, C., Ferrier, J. P., Mihaesco, E., Hurez, D., Seligmann,M. :Nouveau cas de maladie des chaînes alpha chez un eurasien. Ann. Med. Interne (Paris) 121 ,135–148 (1970).
Rambaud, J. C., Modigliani, R., Galian, A., Leclerc, J. P., Hautefeuille, P., Danon, F., Bernier, J. J.: Rémission complète clinique, histologique et immunologique d’un cas de maladie des chaînes alpha traité pendant deux mois par antibiothérapie orale. Gastroenterol. Clin. Biol. (Paris) 2 ,49–61 (1978).
Rambaud, J. C., Seligmann, M.: Alpha-chain disease. Clin. Gastroenterol. 5 ,341–358 (1976).
Ramot, B.: Alpha chain disease and related small intestinal lymphoma. Report of a WHO meeting of investigators. Arch. Fr. Mal. App. Dig. 65 ,591–607 (1976).
Ramot, B., Levanon, M., Hahn, Y., Lahat, N., Moroz, C: The mutual clonal origin of the lymphoplasmocytic and lymphoma cell in alpha-heavy chain disease. Clin. Exp. Immunol. 27,440–445 (1977).
Ramot, B., Streifler, C.: Raised serum-alkaline phosphatase. Lancet 2 ,587 (1966).
Rappaport, H., Ramot, B., Hulu, N., Park, J. K.: The pathology of so-called Mediterranean abdominal lymphoma with malabsorption. Cancer 29 ,1502–1511 (1972).
Roge, J., Druet, P., Marche, C.: Lymphome méditerranéen avec maladie des chaînes alpha. Triple remission clinique, anatomique et immunologique. Pathol. Biol. (Paris) 18 ,851–858 (1970).
Ross, I. N., Jefferis, R., Johns, P., Thompson, R. A., Asquith, P.: Alpha heavy chain disease complicated by a post nasal lymphoma, responding to antibiotics. Gut 17 ,820 (1976).
Seligmann, M., Danon, F., Hurez, D., Mihaesco, E., Preud’Homme, J. L.: Alpha-chain disease: a new immunoglobulin abnormality. Science 162 ,1396–1397 (1968).
Seligmann, M., Mihaesco, E., Francione, B.: Studies on alpha-chain disease. Ann. N.Y. Acad. Sci. 790, 487–500 (1971).
Seligmann, M., Rambaud, J. C: Alpha-chain disease, a possible model of pathogenesis of human lymphomas. In: The Immunopathology of Lymphoreticular Neoplasms. Good, R. A., Twomey, J. J. (eds). New York: Plenum Press, 1978, p. 425–447.
Teulieres, J. P.: La maladie des chaînes lourdes alpha. M.D. Thesis (1975). Claude Bernard University, Lyon, France.
Wolfelstein-Todel, C., Mihaesco. E., Francione, B.: “Alpha-chain disease” protein Def: Internal deletion of a human immunoglobulin A1 heavy chain. Proc. Natl. Acad. Sci. USA 71, 974–978 (1974).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Rambaud, J.C. et al. (1978). Natural History of α-Chain Disease and the So-called Mediterranean Lymphoma. In: Mathé, G., Seligmann, M., Tubiana, M. (eds) Lymphoid Neoplasias I. Recent Results in Cancer Research, vol 64. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81246-0_32
Download citation
DOI: https://doi.org/10.1007/978-3-642-81246-0_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81248-4
Online ISBN: 978-3-642-81246-0
eBook Packages: Springer Book Archive